We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

MEDLAB Middle East 2021 Brings World of Laboratory Medicine Together Under ‘United by Business’ Show Theme

By LabMedica International staff writers
Posted on 21 Jun 2021
Illustration
Illustration
The 2021 edition of Medlab Middle East, the MENA region’s largest medical laboratory exhibition and congress, took place at the Dubai World Trade Centre from 21-24 June, bringing the global healthcare community together under the show theme of ‘United by Business’.

A host of countries, including the UK, Germany, Austria, Belgium, Israel, Korea, Poland, Spain and the US, participated in the event. A range of key laboratory and trade professionals from across the region attended the live and in-person event. It featured a range of keynote speeches and scientific lectures, industry briefings, product demonstrations and networking opportunities, as well as a series of pre-arranged one-to-one meetings, with an emphasis on creating lasting relationships.

Underscoring the confidence within the industry and the increased demand from laboratory professionals to participate in a physical event, several companies and health authorities exhibited at the event. These included the UAE Ministry for Health and Prevention, the College of American Pathologists, Abbott Laboratories, Horiba, Randox Laboratories, Euroimmun, BioVender Group, Seegene, Stago and Erba Group.

Similar to last year, before travel restrictions and country-wide lockdowns, the event attracted over 23,000 professional visitors from over 140 countries and over 3,800 delegates. A total of 14 country pavilions were present at the 2021 edition of the show. The event featured eight Continuing Medical Education (CME) conferences during the live and in-person event and as part of the show's online element. New to the 2021 conference program was a dedicated focus on COVID-19 which addressed the latest scientific findings on the virus and discussed its impact on health in the region.

These were complemented by returning accredited conferences: Laboratory Management, Clinical Chemistry, Clinical Microbiology, Histopathology, Molecular & Genomic Diagnostics, Haematology and Blood Transfusion. A series of medical speciality days have also been scheduled, with experts presenting the latest advancements in specific clinical specialties, including multi-omics, genetics, and stem cells. Medlab Middle East also hosted a range of dedicated online focus days until July 22 to allow participants to continue to do business as well as featured over 180 educational sessions to choose from. The online event platform for both Arab Health and Medlab Middle East was launched on 23 May and will remain available until 22 July.




New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Online QC Software
Acusera 24•7
Urine Analyzer
respons® UDS100
POC Immunoassay Analyzer
Procise DX

Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
PURITAN MEDICAL